LONG LIFE MAXX, INC. – Trademark Portfolio

Entity Type: 03

LONG LIFE MAXX, INC. holds 37 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 34 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include OCU-MAX, PROSTATA, VEINICIN, and JOURNAL OF LONGEVITY. The owner is based in LOS ANGELES, CA.

6701 CENTER DRIVE WEST

SUITE 1500

LOS ANGELES, CA 90045

37 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (37 results)

Trademark Classifications

LONG LIFE MAXX, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (34 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

16
Paper Goods (3 filings)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does LONG LIFE MAXX, INC. have?

LONG LIFE MAXX, INC. has 37 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 abandoned, 30 cancelled.

What trademark classes does LONG LIFE MAXX, INC. file in?

LONG LIFE MAXX, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are LONG LIFE MAXX, INC.'s most well-known trademarks?

LONG LIFE MAXX, INC.'s registered trademark portfolio includes well-known marks such as OCU-MAX, PROSTATA, VEINICIN, and JOURNAL OF LONGEVITY. These are among 4 currently registered trademarks in the portfolio.

What is LONG LIFE MAXX, INC.'s trademark registration success rate?

LONG LIFE MAXX, INC. has a 11% trademark registration rate, with 4 out of 37 resolved applications resulting in successful registration. Currently, 0 applications are pending review.